-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603. Lymphoid Oncogenesis: Basic: Poster III

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Johnvesly Basappa, PhD1*, Aaron Goldman, PhD2*, Cosimo Lobello, PhD3*, Shengchun Wang, PhD1*, David Rushmore, BS3*, Pin Lu, MD, Ph.D.1*, Reza Nejati, MD3 and Mariusz Wasik, MD1*

1Fox Chase Cancer Center, Philadelphia, PA
2Wistar Institute, Philadelphia, PA
3Fox Chase Cancer Center, PHILADELPHIA, PA

James Nolan, MB, PhD1, Daniel Angelov, MSc, MB1, Darragh Nimmo, BSc1*, Gráinne Holland, MSc1*, Molly Davies, BSc2*, Eugene Dillon, PhD2*, David Reck, BA1*, Craig Monger, PhD1*, Chun-Wei David Chen, PhD3, Gerard L Brien, PhD4,5*, Elisabeth Vandenberghe, MD, PhD6*, Eric Conway, PhD2* and Adrian Bracken, PhD1*

1Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland
2School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland
3Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA
4Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom
5MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom
6Department of Haematology, St James' Hospital, Dublin, Ireland

Yubao Wang, PhD1*, Sanxiong Liu, PhD2*, Hussein Ghamlouch, PhD3*, Faith E Davies, MD2 and Gareth Morgan, M.D., Ph.D.2*

1Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
2Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Langone Health, New York, NY
3Hematology and Cell Therapy, CHU Amiens-Picardie, Amiens, France

Tommaso Gianferri*, Teresa Mack*, Daniel Tews, PhD*, Klaus-Michael Debatin, MD, Professor, Lüder Hinrich Meyer, MD, Professor* and Vera Münch, PhD*

Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany

Sofia R Smith, BS1,2* and George P Souroullas, PhD1,3,4

1Division of Oncology, Washington University in St. Louis, St. Louis, MO
2Department of Medicine, Washington University in St. Louis, Saint Louis, MO
3Department of Medicine, Washington University in St. Louis, St. Louis, MO
4Siteman Comprehensive Cancer Center, Washington University in St. Louis, St. Louis, MO

Kadriye Nehir Cosgun, PhD1*, Mark E Robinson, PhD1*, Nikol Agadzhanian, MSc1*, Zhangliang Cheng, BSc1*, Salim Oulghazi, MD1*, Philipp Berning, MD1*, David Fonseca-Arce1*, Kohei Kume, PhD1*, Jake Fontaine1*, Lai N Chan, PhD1, Jaewoong Lee, PhD1,2*, Fang Yu, PhD3*, Zhijian Qian4, Joo Y. Song, MD5, Wing Chung Chan, MD5, Jianjun Chen, PhD6, Mark M Taketo7*, Hilde Schjerven, PhD8* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2School of Biosystems and Biomedical Sciences, Korea University, Seoul, Korea, Republic of (South)
3Division of Hematology/Oncology, Department of Medicine and Department of Biochemistry and Molecular Biology, The University of Florida, Gainesville, FL
4Division of Hematology/Oncology, Department of Medicine and Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL
5Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, CA
6City of Hope Comprehensive Cancer Center, Duarte, CA
7Graduate School of Medicine, Kyoto University, Kyoto, JPN
8Department of Laboratory Medicine and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA

Vijay Negi, PhD*, Ryan Bertoli, BS*, Emily Muenzer* and Peter D. Aplan, MD

Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Athanasia Liapodimitri1,2*, Oscar Camacho2*, Kayleigh Lunsford2,3*, Ashley R Tetens2,3*, Jordyn Craig-Schwartz2,3*, Kegan Skalitzky2,3*, Karen R Rabin, MD, PhD4,5,6, Andy Feinberg, MD, MPH2* and Michael Koldobskiy, MD, PhD2,3*

1Pediatric Oncology, Sidney Kimmel Comprehensive Cancer, Johns Hopkins University School of Medicine, BALTIMORE, MD
2Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD
3Pediatric Oncology, Sidney Kimmel Comprehensive Cancer, Johns Hopkins University School of Medicine, Baltimore, MD
4Department of Pediatrics, Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX
5Department of Pediatrics, Baylor College of Medicine TX Children's Cancer Center, Houston, TX
6Cancer Center and Division of Pediatric Hematology/Oncology, Texas Children's Hospital, Houston, TX

Clarissa Corinaldesi1*, Antony Holmes, PhD, BSc, MSc1*, Elodie Bal, PhD1*, Zeinab Amini-Farsani, PhD1*, Govind Bhagat, MD2, Laura Pasqualucci, MD1, Katia Basso, PhD1* and Riccardo Dalla-Favera, MD1*

1Institute for Cancer Genetics, Columbia University, New York, NY
2Department of Pathology & Cell Biology, Columbia University, New York, NY

Wenjuan Liao1, Tian Liu1*, Julian Grandvallet Contreras, BS1*, Lynn Heltemes Harris, PhD2*, Tzu Phang, PhD1*, Michael A. Farrar, PhD2, M. Eric Kohler, MD, Ph.D3, Terry J Fry, MD4,5 and Patricia Ernst, PhD1,6

1Department of Pediatrics, Section of Hematology/Oncology/BMT, University of Colorado Anschutz Medical Campus, Aurora, CO
2Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
3Department of Pediatrics-Hematology, Oncology, and BMT, University of Colorado Anschutz Medical Campus, Aurora, CO
4Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado Anschutz Medical Campus, Aurora, CO
5Immunology Department and HI3 Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO
6Pharmacology Department, University to University of Colorado Anschutz Medical Campus, Aurora, CO

Eugenio Morelli, MD1,2,3, Anil Aktas-Samur, PhD3,4*, Domenico Maisano, PhD, MSc3,4*, Claire Gao, BS4*, Vanessa Favasuli, PhD4*, Dimitrios Papaioannou, MD5, Na Liu, MS4*, Marcello Turi, PhD1*, Pietro Folino, M.Sc6*, Laure Vreux, Ph.D.7,8*, Michela Cumerlato, MS4*, Liang Cheng, MS7*, Iannis Aifantis, PhD9, Mariateresa Fulciniti, PhD4, Kenneth C. Anderson, MD10, Annamaria Gulla, MD1, Mehmet K. Samur, PhD4 and Nikhil C. Munshi, MD4

1Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy
2Department of Medical Oncology, University of Turin, Turin, Italy
3equally contributed, #, Italy
4Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
5Perlmutter Cancer Center, Department of Medicine, Division of Hematology/Oncology, NYU Grossman School of Medicine, New York, NY, New York, NY
6Dana Farber Cancer Institute, Boston, MA
7Medical Oncology, Dana-Farber Cancer Institute, Boston
8Harvard Medical School, Boston
9Department of Pathology, NYU Grossman School of Medicine, New York, NY
10Dana Farber Cancer Institute, Harvard Medical School, Boston, MA

Karena Hsijan Lin1*, Annie Wang2*, Kailey Lashbrook2*, Kaitlyn Chan2*, Elizabeth Choe3*, Ashwin Iyer4*, Kelly R. Barnett, PhD5*, Daniel Savic, PhD5, Russell J. H. Ryan, MD6 and Mark Chiang, MD, PhD3

1Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI
2University of Michigan, Ann Arbor
3University of Michigan, Ann Arbor, MI
4Regeneron Pharmaceuticals, Tarrytown, NY
5St. Jude Children's Research Hospital, Memphis, TN
6Department of Pathology, University of Michigan Medical School, Ann Arbor, MI

Giulia Calabretto1,2,3*, Elena Buson3*, Zachary Hutchins1*, Colleen Isabelle4, Sydnee Scozzafava1*, Valentina Trimarco2*, Barbara Mariotti5*, Rachel Burzinski1*, Amy Boles1*, Elisa Rampazzo2,3*, Antonella Teramo2,3*, Sabrina Manni2,3*, Monica Facco2,3*, Gregorio Barilà6*, Flavia Bazzoni5*, Gianpietro Semenzato3*, Livio Trentin2, Jonathan E. Brammer7, Renato Zambello2,3* and Anjali Mishra1

1Thomas Jefferson University, Sydney Kimmel Cancer Center, Philadelphia, PA
2Department of Medicine, Hematology and Clinical Immunology section, Padua University School of Medicine, Padova, Italy
3Veneto Institute of Molecular Medicine (VIMM), Padova, Italy
4Thomas Jefferson University, Philadelphia, PA
5Department of Medicine, Division of General Pathology, University of Verona, Verona, Italy
6Hematology Unit, Ospedale San Bortolo, Vicenza, Italy
7Division of Hematology, The Ohio State University, Columbus, OH

Srikanth Talluri, PhD1,2*, Leutz Buon, MS1*, Jiangning Zhao, MD, PhD1*, Daniel Meglino, BS1*, Chandraditya Chakraborty, PhD1*, Chengcheng Liao, MD, PhD1*, Mehmet K. Samur, PhD1, David E. Root, PhD3*, Masood A. Shammas, PhD1,2* and Nikhil C. Munshi, MD2,4

1Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
2VA Boston Healthcare System, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Dana Farber Cancer Institute, The Jerome Lipper Myeloma Center, Boston, MA

*signifies non-member of ASH